HIV/AIDS Treatment Guidelines Search Results| NIH

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Search Results 81 – 100 of 160

Hepatitis C Virus/HIV Coinfection

Tuberculosis/HIV Coinfection

Diagnosis of HIV Infection in Infants and Children

Initial Postnatal Management of the Neonate Exposed to HIV

Long-Term Follow-Up of Infants Exposed to Antiretroviral Drugs

Limitations to Treatment Safety and Efficacy

Adherence to the Continuum of Care

Appendix A: Key to Acronyms

Adverse Effects of Antiretroviral Medications

Drug Name Abbreviations

Cost Considerations and Antiretroviral Therapy

Study and Trial Names

Appendix B: Safety and Toxicity of Individual Antiretroviral Agents in Pregnancy

Drug-Drug Interactions

Overview: Drug-Drug Interactions between Antiretrovirals and Other Drugs

Drug-Drug Interactions: Protease Inhibitors and Other Drugs

Table 14. Antiretroviral Drug Use in Pregnant People With HIV: Pharmacokinetic and Toxicity Data in Human Pregnancy and Recommendations for Use in Pregnancy | Overview

Nucleoside and Nucleotide Analogue Reverse Transcriptase Inhibitors

Abacavir (Ziagen, ABC)